Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Obstructive Hypertrophic Cardiomyopathy. Show all posts
Showing posts with label Obstructive Hypertrophic Cardiomyopathy. Show all posts
Wednesday, July 22, 2026

FDA Approves Myqorzo (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

›
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the U.S. Food and Drug Administration (FDA) approval of  Myqorzo™ (aficamten, 5 mg, 10 m...
Thursday, April 16, 2026

ACC: Mavacamten Efficacious for Adolescents With Obstructive Hypertrophic Cardiomyopathy

›
In continuation of my update on  Mavacamten Mavacamten, the first-in-class cardiac myosin inhibitor approved for treatment of symptomatic ad...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.